Brain Stimulation for Epilepsy and Memory Control
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how certain brain waves, such as theta and alpha, affect memory and how brain stimulation might help manage epilepsy and improve memory control. It uses direct brain stimulation (Direct Cortical Stimulation, or DCS) in various ways to determine the most effective method. Participants will perform tasks while receiving stimulations to specific brain areas. Ideal candidates for this trial are individuals with epilepsy who already have electrodes in place from previous treatments. As an unphased trial, this study provides a unique opportunity to contribute to groundbreaking research on brain stimulation and memory control.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
What prior data suggests that this brain stimulation method is safe for epilepsy and memory control?
In a previous study, researchers used direct cortical stimulation (DCS) safely in patients with epilepsy. This method sends small electrical pulses to the brain to help manage seizures. For example, the Neuropace RNS system employs a similar approach and is already available for epilepsy patients. Research shows that this type of brain stimulation is generally well-tolerated.
Additionally, studies suggest that direct stimulation can aid memory tasks by boosting brain activity. The reviewed studies have not reported significant serious side effects linked to this kind of brain stimulation, suggesting it is a relatively safe treatment option for conditions like epilepsy and memory control.
Overall, data from past research show that DCS has been safely tested, particularly for managing seizures and improving memory functions. However, like all treatments, individual responses can vary, and participants in clinical trials may experience different effects.12345Why are researchers excited about this trial?
Researchers are excited about these brain stimulation techniques because they offer a fresh approach to treating epilepsy and memory control issues. Unlike standard medications that often focus on altering neurotransmitter levels, Direct Cortical Stimulation (DCS) involves applying electrical impulses directly to specific brain regions, which may lead to more precise control of brain activity. The use of different frequencies—alpha and theta—also opens up the possibility of customizing treatments based on individual needs, potentially improving efficacy and reducing side effects. This innovative approach could lead to faster and more targeted relief for patients who haven't responded well to existing options.
What evidence suggests that this trial's treatments could be effective for epilepsy and memory control?
This trial will compare different approaches to direct cortical stimulation (DCS) for epilepsy and memory control. Research has shown that DCS can influence brain activity and improve working memory. Participants may receive DCS targeting the frontal cortex at alpha and theta frequencies, which studies suggest can enhance memory tasks by affecting brain rhythms. Alternatively, some participants will receive DCS targeting both the frontal and parietal cortex at in-phase and anti-phase theta frequencies. Evidence suggests that DCS at specific frequencies helps coordinate memory processing. Additionally, researchers have used DCS to identify brain areas involved in seizures, indicating potential for epilepsy treatment. These findings suggest that DCS might effectively improve memory and manage epilepsy symptoms.678910
Who Is on the Research Team?
Flavio Frohlich, PhD
Principal Investigator
UNC Chapel Hill
Are You a Good Fit for This Trial?
This trial is for patients with medically intractable epilepsy who have had electrodes implanted for monitoring. They must be able to consent, speak English, and not have other major neurological illnesses, severe cognitive or psychiatric conditions, substance abuse issues, or any risk factors that could affect their participation as judged by the investigator.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Phase One: Frontal Stimulation
Direct Cortical Stimulation (DCS) in alpha and theta frequencies is applied through electrodes located in the frontal cortex.
Phase Two: Frontal Parietal Stimulation
Direct Cortical Stimulation (DCS) in in-phase and anti-phase theta frequencies is applied through electrodes located in the frontal and parietal cortex.
Follow-up
Participants are monitored for safety and effectiveness after stimulation sessions
What Are the Treatments Tested in This Trial?
Interventions
- Direct cortical stimulation (DCS) Alpha
- Direct cortical stimulation (DCS) Anti-Phase Theta
- Direct cortical stimulation (DCS) In-Phase Theta
- Direct cortical stimulation (DCS) Theta
- Sham Direct cortical stimulation (DCS)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of North Carolina, Chapel Hill
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator